Fundraising FoxAtlas Venture — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
IFM Therapeutics develops small-molecule drugs that target the innate immune system to treat inflammation-driven diseases and cancer.
BiotechHealthtechCambridge, US
Gary D. Glick(Founder)inH. Martin Seidel(Chief Executive Officer)in
BoardJean-Francois Formela(Director)in
Board seatJean-François Formela· per SEC Form D
Co-investorsAbingworth
Precision medicine company developing therapeutics for genetically-defined age-related macular degeneration.
BiotechCambridge, US
James McLaughlin(Executive Officer, Director)in
BoardJean George(Director)Jason Rhodes(Director)inCarl Gordon(Director)in
Co-investorsAltium CapitalLightstone VenturesOrbiMed
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Morphic Holding, Inc.Delinia
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.